{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:18:54Z","timestamp":1785161934579,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T04:54:10Z","timestamp":1691816050000},"page":"5782-5790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Broad immunogenic spectrum of monovalent and trivalent foot-and-mouth disease virus vaccines containing O1 campos, A24 cruzeiro and A Argentina 2001 strains against circulating viral lineages in cattle and pigs"],"prefix":"10.1016","volume":"41","author":[{"given":"Viviana","family":"Malirat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Caldevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Galdo","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Taffarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Barrios","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.007_b0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.mi.22.100168.001221","article-title":"Foot-and-mouth disease","volume":"22","author":"Bachrach","year":"1968","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2023.08.007_b0010","first-page":"333","article-title":"Foot-and-mouth disease","volume":"vol. 2","author":"Pereira","year":"1981"},{"key":"10.1016\/j.vaccine.2023.08.007_b0015","first-page":"233","article-title":"Genetic variability and antigenic diversity of foot-and-mouth disease virus","volume":"vol. 2","author":"Domingo","year":"1990"},{"key":"10.1016\/j.vaccine.2023.08.007_b0020","unstructured":"WOAH-FAO Foot-and-Mouth Disease Reference Laboratory Network. Annual Report 2021. https:\/\/www.wrlfmd.org\/sites\/world\/files\/quick_media\/OIE-FAO%20FMD%20Ref%20Lab%20Network%20Report%202021.pdf [accessed May 7, 2023]."},{"key":"10.1016\/j.vaccine.2023.08.007_b0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3201\/eid1112.050908","article-title":"Pandemic strain of foot-and-mouth disease virus serotype O","volume":"11","author":"Knowles","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.007_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(02)00260-5","article-title":"Molecular epidemiology of foot-and-mouth disease virus","volume":"91","author":"Knowles","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.007_b0035","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0264-410X(98)00443-5","article-title":"Vital elements for the successful control of foot-and-mouth disease by vaccination","volume":"17","author":"Garland","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.007_b0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1586\/14760584.4.6.903","article-title":"Evolving perception on the benefits of vaccination as foot-and-mouth disease control policy: contributions of South America","volume":"4","author":"Bergmann","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.007_b0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0034-5288(18)32391-9","article-title":"Stimulation of heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle","volume":"32","author":"Cartwright","year":"1982","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2023.08.007_b0050","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.vaccine.2004.06.040","article-title":"Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease","volume":"22","author":"Mattion","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines. Review","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.007_b0060","series-title":"Foot-and-mouth disease controlstrategies","first-page":"331336","article-title":"South American Standards for foot and mouth disease vaccine quality","author":"Allende","year":"2003"},{"key":"10.1016\/j.vaccine.2023.08.007_b0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vetmic.2012.10.035","article-title":"Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern cone of South America and cross protection studies with the vaccine strain in use in the region","volume":"162","author":"Maradei","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2023.08.007_b0070","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.vaccine.2011.08.120","article-title":"Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009\u20132010 and cross-protection studies with the vaccine strain in use in the region","volume":"29","author":"Maradei","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0075","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2016.06.073","article-title":"Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador","volume":"34","author":"Duque","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0080","unstructured":"PANAFTOSA\/OPS\/PAHO Centro Panamericano de Fiebre Aftosa (Pan American Foot and Mouth Disease Center)\/Organizaci\u00f3n Panamericana de la Salud\/Pan American Health Organization. Informe anual del laboratorio (Laboratory annual report); 2019."},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.007_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.20506\/rst.30.1.2022","article-title":"Combining livestock trade patterns with phylogenetics to help understand the spread of foot and mouth disease in sub-Saharan Africa, the Middle East and Southeast Asia","volume":"30","author":"Di Nardo","year":"2011","journal-title":"Rev Sci Tech-OIE"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.007_b0090","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1111\/tbed.12299","article-title":"Outbreaks of foot-and-mouth disease in Libya and Saudi Arabia during 2013 due to an exotic O\/ME-SA\/Ind-2001 lineage virus","volume":"63","author":"Knowles","year":"2016","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.007_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32693-8","article-title":"Reconstructing the evolutionary history of pandemic foot-and-mouth disease viruses: impact of recombination within the emerging O\/ME-SA\/Ind-2001 lineage","volume":"8","author":"Bachanek-Bankowska","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.08.007_b0100","article-title":"Molecular detection and phylogenetic analysis of newly emerging foot-and-mouth disease virus type A lineage EURO-SA in Egypt in 2022","author":"Hagag","year":"2022","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.007_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.14612","article-title":"Emergence of foot and mouth disease virus, serotype O Europe-South America topotype in Egypr, 2022","author":"Soltan","year":"2022","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2023.08.007_b0110","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.vaccine.2017.03.026","article-title":"Antigenic and immunogenic spectrum of foot-and-mouth disease vaccines strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade","volume":"35","author":"Galdo Novo","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.007_b0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.20506\/rst.18.1.1154","article-title":"Managing an animal health emergency in Taipei China: foot and mouth disease","volume":"18","author":"Chen","year":"1999","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.vaccine.2023.08.007_b0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/vr.145.25.731","article-title":"Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan","volume":"145","author":"Yang","year":"1999","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2023.08.007_b0125","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.vaccine.2018.02.015","article-title":"Efficacy of a high quality O1\/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs","volume":"36","author":"Galdo Novo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0130","unstructured":"SENASA. Actual\u00edzase la reglamentaci\u00f3n que permite el control de las vacunas destinadas a la prevenci\u00f3n de la Fiebre Aftosa. (Bolet\u00edn Oficial N_ 30.940 Servicio Nacional de Sanidad y Calidad Agroalimentaria, Argentina (SENASA); 2006."},{"key":"10.1016\/j.vaccine.2023.08.007_b0135","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1016\/j.vaccine.2008.09.033","article-title":"Updating of the correlation between IpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphthovirus vaccines in Argentina","volume":"26","author":"Maradei","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0140","series-title":"Foot-and-mouth disease virus current research and emerging trends","article-title":"Quality attributes of current inactivated foot-and mouth disease vaccines and effects on the success of vaccination programmes","author":"Smitsaart","year":"2016"},{"key":"10.1016\/j.vaccine.2023.08.007_b0145","unstructured":"WOAH World Organization for Animal Health. Foot and mouth disease. In: OIE Standards Commission, editor. Manual of diagnostic tests and vaccines for terrestrial animals. Paris, France; 2022. https:\/\/www.woah.org\/fileadmin\/Home\/eng\/Health_standards\/tahm\/3.01.08_FMDV.pdf [Accessed 08 December]."},{"key":"10.1016\/j.vaccine.2023.08.007_b0150","unstructured":"European Pharmacopoeia. Foot-and-mouth disease (ruminants) vaccine (inactivated) 01\/2017:0063, 9th ed.; 2017."},{"key":"10.1016\/j.vaccine.2023.08.007_b0155","unstructured":"WRLFMD: World Reference Laboratory for FMD. Recommendation to AgResults on using serological indicators (\u201cvalency testing\u201d) of cross-1 protection for FMD vaccines; 2022. https:\/\/www.wrlfmd.org\/sites\/world\/files\/quick_media\/Cross-neutralization%20measure%20AgResults%20 Final%20v2.1.pdf [accessed November 13, 2022]."},{"key":"10.1016\/j.vaccine.2023.08.007_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1027006","article-title":"Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination","author":"Gubbins","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2023.08.007_b0165","series-title":"Pan-American Foot-and-Mouth Disease Center, Report on the \u2018\u2018Subproyecto para la correlaci\u00f3n de las t\u00e9cnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los pa\u00edses de la Cuenca del R\u00edo de la Plata\u201d PANAFTOSA","author":"PANAFTOSA","year":"1994"},{"key":"10.1016\/j.vaccine.2023.08.007_b0170","unstructured":"Perez Beascoechea C, Galdo Novo S, D\u2019Aloia R, Esteves Madero J, Maradei E. Virus de Fiebre Aftosa A Argentina 2001: Correlacion de titulos de anticuerpos neutralizantes con la proteccion al desafio viral in vivo por medio de la Expectativa Porcentual de Proteccion. Desarrollo de una curva de correlacion de tipo Logit. XIII Congreso Argentino de MicrobiologiaCAM. (XIII Argentine Congress of Microbiology), Sept 23\u201326. Buenos Aires, Argentina; 2013."},{"key":"10.1016\/j.vaccine.2023.08.007_b0175","unstructured":"Bergmann IE, Pedemonte A, Malirat V, Galdo Novo S, Maradei ED. Challenges in FMDV strain selection as an input to attain broad vaccine cross-protection. Global Foot-and and Mouth Disease Research Alliance, Scientific Meeting, Oct 29\u201331, Bangkok, Thailand; 2019."},{"key":"10.1016\/j.vaccine.2023.08.007_b0180","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2021.1877137","article-title":"Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection","author":"Bergmann","year":"2021","journal-title":"Expert Rev Vac"},{"key":"10.1016\/j.vaccine.2023.08.007_b0185","unstructured":"Galdo Novo S, Taffarel AI, Caldevilla CA, Ham A, Filippi, Cisneros L, et al., Foot-and-Mouth disease vaccines containing O1 Campos, A24 Cruzeiro and A2001 Argentina: high antigenic relatedness and cross-protection upon challenge with A\/Asia\/SEA-97 and O\/ME-SA\/IND 2001e lineages. Global Foot-and and Mouth Disease Research Alliance, Scientific Meeting, Nov. 1\u20133; 2021."},{"key":"10.1016\/j.vaccine.2023.08.007_b0190","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0264-410X(00)00399-6","article-title":"The suitability of the emergency foot-and-mouth disease antigens held by the International Vaccine Bank within a global context","volume":"19","author":"Barnett","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2023.08.007_b0195","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2018.11.080","article-title":"Cross-protective efficacy of the O1 Manisa+O3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O\/Jincheon\/SKR\/2014 in pig","volume":"37","author":"Kim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0200","doi-asserted-by":"crossref","first-page":"1781 -","DOI":"10.3390\/v14081781","article-title":"Assessement on different vaccine formulation parameters in the protection against heterologous challenge with FMDV in cattle","volume":"14","author":"Di Giacomo","year":"2022","journal-title":"Viruses"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2023.08.007_b0205","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.vaccine.2004.06.040","article-title":"Reintroduction of foot-and-mouth disease in Argentina: characterization of the isolates and development of tools for the control and eradication of the disease","volume":"22","author":"Mattion","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-1702(02)00262-9","article-title":"Control and eradication of foot-and-mouth disease Review","volume":"91","author":"Sutmoller","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.007_b0215","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0220","series-title":"Current perspectives","first-page":"305","article-title":"Modern inactivated foot-and-mouth disease (FMD) vaccines historical background and key elements in production and use in foot and mouth disease","author":"Barteling","year":"2004"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.007_b0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-1157(84)80013-X","article-title":"Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction","volume":"12","author":"Rweyemamu","year":"1984","journal-title":"Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.007_b0230","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/jvi.66.4.1835-1840.1992","article-title":"Protective immune response against foot-and-mouth disease","volume":"66","author":"McCullough","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.007_b0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2008.11.026","article-title":"Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology","volume":"27","author":"Mattion","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0240","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1016\/j.vaccine.2010.07.012","article-title":"Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests","volume":"28","author":"Robiolo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0245","first-page":"153","article-title":"The use of serum neutralising antibody assay for the determination of the potency of foot-and-mouth disease vaccines in cattle","volume":"64","author":"Pay","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2023.08.007_b0250","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/S0264-410X(03)00219-6","article-title":"Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach","volume":"21","author":"Barnett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0255","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/vr.c2300","article-title":"Recent spread of foot-and-mouth disease in the Far East","volume":"166","author":"Paton","year":"2010","journal-title":"Veter Rec"},{"key":"10.1016\/j.vaccine.2023.08.007_b0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3201\/eid1803.110908","article-title":"Southeast Asian foot-and-mouth disease viruses in Eastern Asia","volume":"18","author":"Knowles","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.007_b0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1292\/jvms.11-0271","article-title":"The 2010 foot\u00adand-mouth disease epidemic in Japan","volume":"74","author":"Muroga","year":"2012","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2023.08.007_b0270","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3201\/eid1904.121320","article-title":"Control of foot-and\u00admouth disease during 2010\u20132011 epidemlc South Korea","volume":"19","author":"Park","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.007_b0275","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.vaccine.2014.01.067","article-title":"Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and mouth disease type O caused an epidemic in East Asia during 2010\/2011","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7774\/cevr.2016.5.1.83","article-title":"Novel foot-and-mouth disease virus in Korea, July-August 2014","volume":"5","author":"Park","year":"2016","journal-title":"Clin Exp Vaccine Res"},{"issue":"51","key":"10.1016\/j.vaccine.2023.08.007_b0285","first-page":"7147","article-title":"Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007\u20132012) circulating in Southeast Asia","volume":"35","author":"Mahapatra","year":"2017","journal-title":"East Asia and Far East Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.007_b0290","doi-asserted-by":"crossref","unstructured":"Blackswell SD, Siengsanan-Lamont J, Kamolsiripichaiporn S, Gleeson LJ, Windsor PA. A history of FMD research and control programmes in Southeast Asia: lessons from the past informing the future. Epidemiol Infect 147, e171, 1\u201313. 10.1017\/S0950268819000578.","DOI":"10.1017\/S0950268819000578"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.007_b0295","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","article-title":"Foot and mouth disease vaccine strain selection: current approaches and future perspectives","volume":"17","author":"Mahapatra","year":"2018","journal-title":"Expert Rev Vac"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T13:46:36Z","timestamp":1736343996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":59,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009398"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad immunogenic spectrum of monovalent and trivalent foot-and-mouth disease virus vaccines containing O1 campos, A24 cruzeiro and A Argentina 2001 strains against circulating viral lineages in cattle and pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}